Atlas Trials

A Long Term Study of a Medication for Adults With Attention-Deficit/Hyperactivity Disorder (ADHD)

Clinical trial NCT00700427 · COMPLETED

Trial details

NCT number
NCT00700427
Sponsor
Eli Lilly and Company
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Attention Deficit Hyperactivity Disorder
Start date
2008-06-01
Primary completion
2011-08-01
Enrollment
2017

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.